Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

298 evidence items · page 5 / 12

34.6 %34.6% of the 231 women cited invasion of privacy by male doctors as a reason for avoiding cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2021Cancer treatment and research communicationsPubMeddocument of 11 observations

7 %VIA positivity was 7% among women living with HIV (WLHIV).

Nigeriacancer du col de l'utérusobserved 2021published 2023BMC public healthPubMeddocument of 12 observations

94 %Among 400 female students in tertiary institutions in Imo State, 376 (94%) cited embarrassment as the most prevalent reason for not undertaking cervical screening.

Nigeriacancer du col de l'utéruspublished 2021Journal of community healthPubMeddocument of 9 observations

9 %Uptake of cervical cancer screening among mothers of female secondary school students in Abakaliki was 9%.

Nigeriacancer du col de l'utéruspublished 2019Nigerian journal of clinical practicePubMeddocument of 7 observations

50 %The most common stage at presentation was FIGO Stage IIB in 50% of patients.

Nigeriacancer du col de l'utéruspublished 2025BrachytherapyPubMeddocument of 8 observations

Cervical cancer is the second most common cancer in women globally.

Nigeriacancer du col de l'utéruspublished 2021Cancer treatment and research communicationsPubMeddocument of 11 observations

73.2 %73.2% of the female postgraduate students at the University of Ibadan preferred female doctors to conduct cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2024BMC women's healthPubMeddocument of 6 observations

7 %Cervical cancer screening rates were 7 to 25% in other West African countries.

Nigeriacancer du col de l'utéruspublished 2026BMC public healthPubMeddocument of 3 observations

34.6 %Comprehensive knowledge of cervical cancer was low (34.6%) among women of reproductive age living with HIV in North Central Nigeria.

Nigeriacancer du col de l'utéruspublished 2025The Pan African medical journalPubMeddocument of 4 observations

0.6 %Uptake of pap smear was 0.6% in the control group at baseline.

Nigeriacancer du col de l'utéruspublished 2022BMC women's healthPubMeddocument of 5 observations

10 %10% of respondents were aware of the human papillomavirus vaccine for the prevention of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations

9 %Only 9.0% of the female secondary school teachers in Enugu metropolis had a programme in their school that addresses cervical cancer or cervical cancer vaccination.

Nigeriacancer du col de l'utérusobserved 2017published 2021The Pan African medical journalPubMeddocument of 7 observations

61.5 %Among 991 women of reproductive age living with HIV in North Central Nigeria, 61.5% had never been screened for cervical cancer.

Nigeriacancer du col de l'utéruspublished 2025The Pan African medical journalPubMeddocument of 4 observations

4 %4% of respondents had been screened with the Papanicolaou test.

Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations

42.7 %Less than half of the respondents had good knowledge of cervical cancer (42.7%).

Nigeriacancer du col de l'utérusobserved April 2021published 2024The Pan African medical journalPubMeddocument of 8 observations

Cervical cancer is the second most frequent cancer among women in Nigeria.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

Cervical cancer is the second leading cause of cancer incidence and mortality among Nigerian women.

Nigeriacancer du col de l'utérusPubMeddocument of 7 observations

48.1 %48.1% of the participants noted that HPV can cause cervical cancer.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2024BMC public healthPubMeddocument of 12 observations

8,685 Instagram accountsSix finalist entries were shared on social media to promote cervical cancer awareness, reaching 8685 individual Instagram accounts and generating 2727 likes and 782 comments.

Nigeriacancer du col de l'utéruspublished 2026JMIR formative researchPubMeddocument of 7 observations

40.9 %40.9% of the women cited lack of knowledge of the importance of being screened for cervical cancer as a reason for not being screened.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

11.1 %11.1% of rural women in North Central Nigeria cited low perceived susceptibility as a barrier to cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations

Cervical cancer is the major cause of cancer deaths in developing countries.

Nigeriacancer du col de l'utéruspublished 2021Journal of preventive medicine and hygienePubMeddocument of 11 observations

242 patientsAmong 343 cervical cancer patients, 242 (70.55%) had stage II or III disease.

Nigeriacancer du col de l'utérusobserved March 2021 to June 2024PubMeddocument of 6 observations

58.1 %58.1% of the study participants had high-grade squamous intraepithelial lesion or invasive cervical cancer (HSIL/ICC).

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesionobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations

57.82 yearsThe average age of 343 cervical cancer patients was 57.82 ± 11.77 years.

Nigeriacancer du col de l'utérusobserved March 2021 to June 2024PubMeddocument of 6 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.